Study Finds Biomarker for Lung Cancer Detection in the Nose

v_butoday_16-10090-AVISPIRA-119

A new nasal test may allow patients suspected of having lung cancer to undergo a simple swab of their nose to determine if they have the disease.  Avi Spira and Marc Lenburg at Boston University School of Medicine (BUSM) have found that a genomic biomarker in the nasal passage can accurately determine the likelihood that a lung lesion is malignant.  The findings, which appear online in the Journal of the National Cancer Institute, will allow physicians to confidently identify patients who are at low probability for having lung cancer, thus sparing them from costly and risky procedures.

http://www.bu.edu/today/2017/lung-cancer-nose-swab/ 

View all posts